JP2022545656A5 - - Google Patents

Info

Publication number
JP2022545656A5
JP2022545656A5 JP2022510109A JP2022510109A JP2022545656A5 JP 2022545656 A5 JP2022545656 A5 JP 2022545656A5 JP 2022510109 A JP2022510109 A JP 2022510109A JP 2022510109 A JP2022510109 A JP 2022510109A JP 2022545656 A5 JP2022545656 A5 JP 2022545656A5
Authority
JP
Japan
Prior art keywords
exosome
cells
mimetic
magnetic nanoparticles
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022510109A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022545656A (ja
JP7765681B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/046050 external-priority patent/WO2021034582A1/en
Publication of JP2022545656A publication Critical patent/JP2022545656A/ja
Publication of JP2022545656A5 publication Critical patent/JP2022545656A5/ja
Application granted granted Critical
Publication of JP7765681B2 publication Critical patent/JP7765681B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022510109A 2019-08-16 2020-08-13 エクソソーム模倣物のラージスケール生成およびそれらの使用 Active JP7765681B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962887876P 2019-08-16 2019-08-16
US62/887,876 2019-08-16
PCT/US2020/046050 WO2021034582A1 (en) 2019-08-16 2020-08-13 Large scale production of exosome mimetics and uses thereof

Publications (3)

Publication Number Publication Date
JP2022545656A JP2022545656A (ja) 2022-10-28
JP2022545656A5 true JP2022545656A5 (cg-RX-API-DMAC7.html) 2023-08-22
JP7765681B2 JP7765681B2 (ja) 2025-11-07

Family

ID=74659601

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022510109A Active JP7765681B2 (ja) 2019-08-16 2020-08-13 エクソソーム模倣物のラージスケール生成およびそれらの使用

Country Status (6)

Country Link
US (1) US20220288241A1 (cg-RX-API-DMAC7.html)
EP (1) EP4013391A4 (cg-RX-API-DMAC7.html)
JP (1) JP7765681B2 (cg-RX-API-DMAC7.html)
CN (1) CN114980869B (cg-RX-API-DMAC7.html)
CA (1) CA3150734A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021034582A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12241888B2 (en) 2018-03-14 2025-03-04 Children's Medical Center Corporation Platform for assessment of the transcytosis of extracellular vesicles across endothelial barriers and uses thereof
CN115137723B (zh) * 2022-09-06 2023-05-05 深圳市茵冠生物科技有限公司 醋酸钙梯度主动载药法制备维a酸外泌体模拟物
CN116200392B (zh) * 2023-02-24 2026-08-11 杭州佰辰医学检验所有限公司 特异性结合丙戊酸钠小分子的核酸适配体、试剂盒及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5667180B2 (ja) * 2009-07-01 2015-02-12 イオン メディックス インコーポレイテッド 哺乳類の有核細胞に由来するマイクロベシクル及びその用途
EA037503B1 (ru) * 2014-01-21 2021-04-05 Анджариум Байосайенсиз Аг Способ получения гибридосомы, гибридосома, полученная при помощи способа, и способ доставки терапевтического или диагностического средства
KR101720851B1 (ko) * 2015-01-29 2017-03-28 포항공과대학교 산학협력단 세포의 지질막에서 유래된 나노소포체 및 이의 용도
CN108175759B (zh) * 2016-12-08 2021-03-19 暨南大学 一种抗肿瘤靶向给药系统及其制备方法与应用
WO2019151744A1 (ko) * 2018-01-31 2019-08-08 서울대학교산학협력단 성체줄기세포 유래의 나노베시클 및 이의 표적 치료용 용도

Similar Documents

Publication Publication Date Title
US20240299302A1 (en) Nanovesicles derived from cell membrane, and use thereof
Gao et al. Multifunctional pathology-mapping theranostic nanoplatforms for US/MR imaging and ultrasound therapy of atherosclerosis
Huang et al. CT/NIRF dual-modal imaging tracking and therapeutic efficacy of transplanted mesenchymal stem cells labeled with Au nanoparticles in silica-induced pulmonary fibrosis
CN103623437B (zh) 一种成像用纳米探针材料及其制备方法和应用
Fifer et al. Positron emission tomography measurement of periodontal 18F-fluorodeoxyglucose uptake is associated with histologically determined carotid plaque inflammation
JP2020189977A (ja) マクロファージおよび他のマンノース結合c型レクチン受容体高発現細胞を標的化するための化合物および組成物、ならびにそれらを使用して治療するおよび診断する方法
US10973927B2 (en) Materials and methods for effective in vivo delivery of DNA nanostructures to atherosclerotic plaques
Teleanu et al. Contrast agents delivery: an up-to-date review of nanodiagnostics in neuroimaging
JP2007169261A (ja) 特異的標的機能を有する蛍光磁気ナノ粒子
Gao et al. Nanoparticles hijack calvarial immune cells for CNS drug delivery and stroke therapy
WO2022257849A1 (zh) 一种工程化囊泡的制备方法及其应用
Tarighatnia et al. Mucin-16 targeted mesoporous nano-system for evaluation of cervical cancer via dual-modal computed tomography and ultrasonography
Garello et al. MRI visualization of neuroinflammation using VCAM-1 targeted paramagnetic micelles
Buchler et al. FDG-PET in bleomycin-induced pneumonitis following ABVD chemotherapy for Hodgkin’s disease-a useful tool for monitoring pulmonary toxicity and disease activity
Ding et al. Platelets as delivery vehicles for targeted enrichment of NO· to cerebral glioma for magnetic resonance imaging
Cheng et al. Advancing immunotherapy in triple negative breast cancer: a novel multimodal theranostic nanoplatform integrating synergetic ferroptosis and photothermal therapy
Thangaleela et al. Nanoparticle-based imaging techniques in neurological disorders
Martelli et al. In vivo imaging of lymph node migration of MNP-and 111In-labeled dendritic cells in a transgenic mouse model of breast cancer (MMTV-Ras)
Yao et al. A folate-conjugated dual-modal fluorescent magnetic resonance imaging contrast agent that targets activated macrophages in vitro and in vivo
Quatre et al. Evaluation of the theranostic properties of gadolinium‐based nanoparticles for head and neck cancer
CN108992418A (zh) 药物组合物、制备方法及其用途
CN106398681A (zh) 基于二氧化硅的pH敏感的荧光纳米材料、其制备方法及其应用
Kiuchi et al. Usefulness of late gadolinium enhancement combined with MRI and 67-Ga scintigraphy in the diagnosis of cardiac sarcoidosis and disease activity evaluation
Wang et al. Design of ligands-conjuncted lipid nanobubbles as ultrasound contrast agents targeted to atherosclerotic plaques
CN107496918B (zh) 一种复合纳米诊疗制剂及其制备方法